Reply to Yasuma et al

Eihab O Bedawi^{1

2

3}, Nikolaos I Kanellakis^{1

2

4

5}, Najib M Rahman^{1

2

4

5}

Affiliations

¹ Oxford Respiratory Trials Unit.
² NIHR Oxford Biomedical Research Centre.
³ Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
⁴ Laboratory of Pleural and Lung Cancer Translational Research, and.
⁵ Chinese Academy of Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; and.

Comment

Eihab O Bedawi et al. Am J Respir Crit Care Med. 2023.

. 2023 Apr 1;207(7):950.

doi: 10.1164/rccm.202211-2110LE.

Eihab O Bedawi^{1

2

3}, Nikolaos I Kanellakis^{1

2

4

5}, Najib M Rahman^{1

2

4

5}

¹ Oxford Respiratory Trials Unit.
² NIHR Oxford Biomedical Research Centre.
³ Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
⁴ Laboratory of Pleural and Lung Cancer Translational Research, and.
⁵ Chinese Academy of Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; and.

No abstract available

Comment on

Is the Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Ratio a Marker of Sonographic Septations in Pleural Infection?
Yasuma T, D'Alessandro-Gabazza CN, Kobayashi T, Gabazza EC, Fujimoto H. Yasuma T, et al. Am J Respir Crit Care Med. 2023 Apr 1;207(7):949. doi: 10.1164/rccm.202210-1916LE. Am J Respir Crit Care Med. 2023. PMID: 36413774 Free PMC article. No abstract available.

1. Bedawi EO, Kanellakis NI, Corcoran JP, Zhao Y, Hassan M, Asciak R, et al. The biological role of pleural fluid PAI-1 and sonographic septations in pleural infection: analysis of a prospectively collected clinical outcome study. Am J Respir Crit Care Med . 2023;207:731–739. - PMC - PubMed